Weidling Ian, Preiss Christina N, Chancellor Sarah E, Srivastava Gyan, Gibilisco Lauren, Lin Gen, Brennan Melanie Shackett, Lee Janice, Roth Lindsay M, Morozova Olga, Nam Kyong Nyon, Patel Nehal R, Liu Qing, Thomas J K, Reinhardt Peter, Wilkens Ruven, Ehrnhoefer Dagmar E, Striebinger Andreas, Barghorn Stefan, Xanthopoulos Christina, Weil Marie-Theres, Biesinger Sandra, Cik Miroslav, Romanul Nandini, Yanamandra Kiran, Welker Alessandra M, Wu Jessica, Gasparini Laura, Stöhr Jan, Langlois Xavier, Manos Justine D
AbbVie, Cambridge Research Center, 200 Sidney Street, Cambridge, MA, 02139, USA.
AbbVie Pte Ltd, 9 North Buona Vista Drive #19-01, Singapore, 138588, Singapore.
Acta Neuropathol Commun. 2025 May 19;13(1):108. doi: 10.1186/s40478-025-02000-4.
Alzheimer's disease (AD) is characterized by the accumulation and spread of Tau intraneuronal inclusions throughout most of the telencephalon, leaving hindbrain regions like the cerebellum and spinal cord largely spared. These neuropathological observations, along with the identification of specific vulnerable sub-populations from AD brain-derived single nuclei transcriptomics, suggest that a subset of brain regions and neuronal subtypes possess a selective vulnerability to Tau pathology. Given the inability to culture neurons from patient brains, a disease-relevant in vitro model which recapitulates these features would serve as a critical tool to validate modulators of vulnerability and resilience. Using our recently established platform for inducing endogenous Tau aggregation in human induced pluripotent stem cell (hiPSC)-derived cortical excitatory neurons via application of AD brain-derived exogenous Tau aggregates, we explored whether Tau aggregates preferentially induce aggregation in specific neuronal subtypes. We compared Tau seeding in hiPSC-derived neuron subtypes representing regional identities across the forebrain, midbrain, and hindbrain. Higher susceptibility (i.e. more Tau aggregation) was consistently observed among cortical neuron subtypes, with CTIP2-positive, somatostatin (SST)-positive cortical inhibitory neurons showing the greatest aggregation levels across hiPSC lines from multiple donors. hiPSC-neurons also delineated between the disease-specific vulnerabilities of different protein aggregates, as α-synuclein preformed fibrils showed an increased propensity to induce aggregates in midbrain dopaminergic (mDA)-like neurons, mimicking Parkinson's disease (PD)-specific susceptibility. Aggregate uptake and degradation rates were insufficient to explain differential susceptibility. The absence of a consistent transcriptional response following aggregate seeding further indicated that intrinsic neuronal subtype-specific properties could drive susceptibility. The present data provides evidence that hiPSC-neurons exhibit features of selective neuronal vulnerability which manifest in a cell autonomous manner, suggesting that mining intrinsic (or basal) transcriptomic signatures of more vulnerable compared to more resilient hiPSC-neurons could uncover the molecular underpinnings of differential susceptibility to protein aggregation found in a variety of neurodegenerative diseases.
阿尔茨海默病(AD)的特征是Tau蛋白神经元内包涵体在大部分端脑累积并扩散,而后脑区域如小脑和脊髓基本未受影响。这些神经病理学观察结果,以及从AD脑源性单核转录组学中鉴定出特定的易损亚群,表明一部分脑区和神经元亚型对Tau病理学具有选择性易损性。鉴于无法从患者大脑中培养神经元,一个能够重现这些特征的疾病相关体外模型将成为验证易损性和恢复力调节因子的关键工具。利用我们最近建立的平台,通过应用AD脑源性外源性Tau聚集体在人诱导多能干细胞(hiPSC)衍生的皮质兴奋性神经元中诱导内源性Tau聚集,我们探究了Tau聚集体是否优先在特定神经元亚型中诱导聚集。我们比较了代表前脑、中脑和后脑区域特征的hiPSC衍生神经元亚型中的Tau种子形成情况。在皮质神经元亚型中始终观察到更高的易感性(即更多的Tau聚集),CTIP2阳性、生长抑素(SST)阳性的皮质抑制性神经元在来自多个供体的hiPSC系中表现出最高的聚集水平。hiPSC神经元还区分了不同蛋白质聚集体的疾病特异性易损性,因为α-突触核蛋白预形成纤维在中脑多巴胺能(mDA)样神经元中诱导聚集的倾向增加,模拟了帕金森病(PD)特异性易感性。聚集体摄取和降解速率不足以解释差异易感性。聚集体接种后缺乏一致的转录反应进一步表明,内在的神经元亚型特异性特性可能驱动易感性。目前的数据提供了证据,表明hiPSC神经元表现出选择性神经元易损性特征,以细胞自主方式表现出来,这表明挖掘更易损与更具恢复力的hiPSC神经元的内在(或基础)转录组特征可能揭示在多种神经退行性疾病中发现的对蛋白质聚集差异易感性的分子基础。